PTK2 and pancreatic neoplasm: When Dasatinib and PF573228 were used together, both Src and FAK activation can be effectively blocked at a relatively lower dose (relative to single inhibitor) (Fig. 5C), indicating that FAK and Src do reciprocally activate each other in pancreatic cancer cell lines.